In Victoria, nurse immunisers, pharmacist immunisers and Aboriginal and Torres Strait Islander health practitioner (ATSIHP) immunisers are authorised to administer the respiratory syncytial virus (RSV) vaccine Arexvy.

RSV is a virus that causes both upper and lower respiratory tract infections. Arexvy is used to prevent RSV in people aged 60 years and older, and is recommended for:

  • All adults aged 75 years and older
  • First Nations adults aged 60 years and older
  • adults aged 60 to 74 years with certain medical conditions.

Read more about Arexvy and RSV on our RSV reference page.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个